Avi Avramoff, Ph.D., joined our Company in October 2011 as Vice President, Head of Research & Development. He is responsible for the Company’s generic and innovative new product development, the management of the R&D Pharma and Chemistry, R&D Analytical Laboratories, Preclinical, Pharmacokinetic and Clinical Studies, Regulatory Affairs, R&D Project Management and Pharmacovigilance in all of Taros’ sites. In addition, he is involved in the new product introduction process from selection to launch and Portfolio Management. He has penned various publications and abstracts in the field of pharmacy, as well as several patents and patent applications. Prior to joining our Company, Dr. Avramoff worked as Vice President, Research & Development at Dexcel Pharma.